Search
Evogene Ltd
EVGNAdd to Watchlist
0.430USD
-0.011-2.56%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.47MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-2.56%
5 Days
+10.49%
1 Month
-29.52%
6 Months
-61.97%
Year to Date
-60.94%
1 Year
-67.93%
Key Figures
0.420Open
0.450High
76.17KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.73%Turnover Ratio
0.441Prev. Close
0.419Low
21.62KTurnover
LossP/E Static
7.41P/B
0.00%Div Yield TTM
-45.06%ROA
2.42052wk High
0.68Volume Ratio
-16.48MNet Profit
10.41MShares
-1.0776EPS TTM
1.36Beta
-482.60%ROE
0.66052wk Low
6.89%Amplitude
61.08%Gross Margin
4.47MMarket Cap
-7.31Reward/Risk
3.78%Risk Rate
TradingKey Stock Score of Evogene Ltd
Currency: USD Updated: 2026-07-02Key Insights
Evogene Ltd's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 162 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.15.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Evogene Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Evogene Ltd Highlights
StrengthsRisks
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.85M.
Fairly Valued
The company’s latest PE is -0.40, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 201.08K shares, decreasing 77.10% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 3.81.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.150
Target Price
+387.53%
Upside Space
Evogene Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Evogene Ltd Info
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Ticker SymbolEVGN
CompanyEvogene Ltd
CEOEmber (Brian)
Websitehttps://evogene.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Evogene Ltd (EVGN)?
The current price of Evogene Ltd (EVGN) is 0.43.
What is the symbol of Evogene Ltd?
The ticker symbol of Evogene Ltd is EVGN.
What is the 52-week high of Evogene Ltd?
The 52-week high of Evogene Ltd is 2.42.
What is the 52-week low of Evogene Ltd?
The 52-week low of Evogene Ltd is 0.66.
What is the market capitalization of Evogene Ltd?
The market capitalization of Evogene Ltd is 4.47M.
Is Evogene Ltd (EVGN) currently rated as Buy, Hold, or Sell?
According to analysts, Evogene Ltd (EVGN) has an overall rating of Buy, with a price target of 2.15.
What is the Earnings Per Share (EPS TTM) of Evogene Ltd (EVGN)?
The Earnings Per Share (EPS TTM) of Evogene Ltd (EVGN) is -1.08.